PAVmed Inc.
PAVmed Inc. (PAVM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
pavm · stock forecast · 3 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $5.32
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.05 | ↓ 5.00% |
1-day model range: $4.96–$5.15. Peak: $5.15 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PAVM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-09 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-12-10 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-10-06 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-06-06 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-12-09 | Ascendiant Capital | Maintains | Buy→Buy |
| 2023-08-17 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2023-01-19 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-01-17 | Lake Street | Maintains | Buy→Buy |
| 2022-08-16 | Lake Street | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on PAVmed Inc. (PAVM) stock. Of the recent 10 rating actions, 0 were upgrades and 1 were downgrades. 3 analysts currently cover PAVM.
Analyst Recommendation Trends
PAVM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$4M
↑ 8504.5% YoY
Revenue Next Year
$3M
↓ 21.3% YoY
EPS This Year
$-8.08
EPS Next Year
$75.00
↓ 1028.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast PAVM EPS of $-8.08 for the current fiscal year, based on estimates from 1 analysts. The PAVM revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PAVM stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PAVM price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The PAVM short-term stock prediction for tomorrow is $5.05 (-5.00%).
PAVmed Inc. trades on NASDAQ under the ticker PAVM. The PAVM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
PAVM forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month PAVM price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $5.32.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.